80.97
0.47%
+0.38
After Hours:
80.97
Bruker Corp stock is currently priced at $80.97, with a 24-hour trading volume of 450.65K.
It has seen a +0.47% increased in the last 24 hours and a -12.37% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $80.69 pivot point. If it approaches the $81.39 resistance level, significant changes may occur.
Previous Close:
$80.59
Open:
$80.6
24h Volume:
450.65K
Market Cap:
$11.77B
Revenue:
$2.96B
Net Income/Loss:
$427.20M
P/E Ratio:
37.31
EPS:
2.17
Net Cash Flow:
$243.20M
1W Performance:
+4.13%
1M Performance:
-12.37%
6M Performance:
+40.28%
1Y Performance:
+4.49%
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978-663-3660
Address
40 Manning Road, Billerica, MA
Bruker Corp Stock (BRKR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
Dec-13-23 | Initiated | Wolfe Research | Outperform |
Oct-21-22 | Initiated | UBS | Buy |
Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
Oct-15-21 | Resumed | Cowen | Market Perform |
Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Dec-02-20 | Initiated | Goldman | Sell |
Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jan-07-20 | Initiated | Citigroup | Buy |
Nov-15-19 | Initiated | Stifel | Hold |
Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
Jun-24-19 | Reiterated | Needham | Strong Buy |
Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
May-30-19 | Initiated | Wolfe Research | Peer Perform |
May-06-19 | Reiterated | Needham | Strong Buy |
May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
May-03-19 | Upgrade | UBS | Sell → Neutral |
Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
Feb-12-19 | Reiterated | BTIG Research | Buy |
Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline
Zacks Investment Research
Bruker (BRKR) Introduces Magnet Technology for NMR Adoption
Zacks Investment Research
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
Zacks Investment Research
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
Zacks Investment Research
Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?
Zacks Investment Research
Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO
Zacks Investment Research
Bruker Corp Stock (BRKR) Financials Data
Bruker Corp (BRKR) Revenue 2024
BRKR reported a revenue (TTM) of $2.96 billion for the quarter ending December 31, 2023, a +17.14% rise year-over-year.
Bruker Corp (BRKR) Net Income 2024
BRKR net income (TTM) was $427.20 million for the quarter ending December 31, 2023, a +44.03% increase year-over-year.
Bruker Corp (BRKR) Cash Flow 2024
BRKR recorded a free cash flow (TTM) of $243.20 million for the quarter ending December 31, 2023, a +67.49% increase year-over-year.
Bruker Corp (BRKR) Earnings per Share 2024
BRKR earnings per share (TTM) was $2.92 for the quarter ending December 31, 2023, a +46.73% growth year-over-year.
Bruker Corp Stock (BRKR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Requardt Hermann Fritz | Director |
Mar 04 '24 |
Option Exercise |
22.05 |
15,000 |
330,750 |
38,147 |
Requardt Hermann Fritz | Director |
Mar 04 '24 |
Sale |
90.06 |
15,000 |
1,350,898 |
23,147 |
Busse Falko | PRESIDENT, BIOSPIN GROUP |
Feb 28 '24 |
Option Exercise |
26.28 |
28,122 |
739,156 |
60,981 |
Busse Falko | PRESIDENT, BIOSPIN GROUP |
Feb 28 '24 |
Sale |
85.48 |
28,122 |
2,403,890 |
32,859 |
Prause Burkhard | PRES. & CEO, BRUKER BEST |
Feb 22 '24 |
Option Exercise |
43.17 |
5,450 |
235,292 |
32,384 |
Prause Burkhard | PRES. & CEO, BRUKER BEST |
Feb 22 '24 |
Sale |
83.30 |
15,319 |
1,276,073 |
17,065 |
LINTON WILLIAM A | Director |
Dec 05 '23 |
Option Exercise |
19.07 |
10,000 |
190,700 |
33,048 |
LAUKIEN FRANK H | PRESIDENT & CEO |
Oct 26 '23 |
Option Exercise |
46.14 |
59,523 |
2,746,689 |
38,327,911 |
LAUKIEN FRANK H | PRESIDENT & CEO |
Aug 08 '23 |
Option Exercise |
47.85 |
44,150 |
2,112,578 |
38,255,291 |
LAUKIEN FRANK H | PRESIDENT & CEO |
Aug 08 '23 |
Sale |
64.81 |
37,947 |
2,459,345 |
38,217,344 |
About Bruker Corp
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.
Cap:
|
Volume (24h):